June 22, 2012 - Bio-Signal Group announces that the U.S. Food and Drug Administration has cleared the Company’s microEEG® System for commercial distribution.

The microEEG® System is a miniature, semi-disposable, wireless clinical platform technology capable of recording electroencephalograms (EEG) that is fast, portable, and easy-to-use. The system employs BSG-developed high- fidelity digital wireless electrophysiological recording technology which simplifies the recording process and makes EEG and its interpretation possible in scenarios which were previously not feasible.

U.S. and other patents pending.
© Bio-Signal Group Corp. 2012